2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2006060664v1 18/2/421    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lim, S. W. Articles by Kwon, H. M. Search for Related Content PubMed PubMed Citation Articles by Lim, S. W. Articles by Kwon, H. M.

Downregulation of Renal Sodium Transporters and Tonicity-Responsive Enhancer Binding Protein by Long-Term Treatment with Cyclosporin A

Sun Woo Lim^*, Kyung Ohk Ahn, Mee Rie Sheen^*, Un Sil Jeon^*, Jin Kim, Chul Woo Yang and H. Moo Kwon^*

^* Department of Medicine, University of Maryland, Baltimore, Maryland; and Departments of; Medicine; and Anatomy, Catholic University of Korea, Seoul, Korea

Address correspondence to: Dr. H. Moo Kwon, 22 South Greene Street, Nephrology N3W143, Baltimore, MD 21201. Phone: 410-706-4382; Fax: 410-706-4313; mkwon{at}medicine.umaryland.edu

Received for publication June 27, 2006. Accepted for publication October 30, 2006.

Tonicity-responsive enhancer binding protein (TonEBP) is a transcriptional activator that is regulated by ambient tonicity. TonEBP protects the renal medulla from the deleterious effects of hyperosmolality and regulates the urinary concentration by stimulating aquaporin-2 and urea transporters. The therapeutic use of cyclosporin A (CsA) is limited by nephrotoxicity that is manifested by reduced GFR, fibrosis, and tubular defects, including reduced urinary concentration. It was reported recently that long-term CsA treatment was associated with decreased renal expression of TonEBP target genes, including aquaporin-2, urea transporter, and aldose reductase. This study tested the hypothesis that long-term CsA treatment reduces the salinity/tonicity of the renal medullary interstitium as a result of inhibition of active sodium transporters, leading to downregulation of TonEBP. CsA treatment for 7 d did not affect TonEBP or renal function. Whereas expression of sodium transporters was altered, the medullary tonicity seemed unchanged. Conversely, 28 d of CsA treatment led to downregulation of TonEBP and overt nephrotoxicity. The downregulation of TonEBP involved reduced expression, cytoplasmic shift, and reduced transcription of its target genes. This was associated with reduced expression of active sodium transporters—sodium/potassium/chloride transporter type 2 (NKCC2), sodium/chloride transporter, and Na⁺,K⁺-ATPase—along with increased sodium excretion and reduced urinary concentration. Infusion of vasopressin restored the expression of NKCC2 in the outer medulla as well as the expression and the activity of TonEBP. It is concluded that the downregulation of TonEBP in the setting of long-term CsA administration is secondary to the reduced tonicity of the renal medullary interstitium.

This article has been cited by other articles:

				A. Andres-Hernando, M. A. Lanaspa, C. J. Rivard, and T. Berl Nucleoporin 88 (Nup88) Is Regulated by Hypertonic Stress in Kidney Cells to Retain the Transcription Factor Tonicity Enhancer-binding Protein (TonEBP) in the Nucleus J. Biol. Chem., September 5, 2008; 283(36): 25082 - 25090. [Abstract] [Full Text] [PDF]

				M. S. Kwon, S. D. Lee, J.-A. Kim, E. Colla, Y. J. Choi, P.-G. Suh, and H. M. Kwon Novel Nuclear Localization Signal Regulated by Ambient Tonicity in Vertebrates J. Biol. Chem., August 15, 2008; 283(33): 22400 - 22409. [Abstract] [Full Text] [PDF]

				U. S. Jeon, K.-H. Han, S.-H. Park, S. D. Lee, M. R. Sheen, J.-Y. Jung, W. Y. Kim, J. M. Sands, J. Kim, and H. M. Kwon Downregulation of renal TonEBP in hypokalemic rats Am J Physiol Renal Physiol, July 1, 2007; 293(1): F408 - F415. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673